Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Pharmacology Research & Perspectives
|
July 15, 2015
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates
Yihui Shi, Amanda S Joyner, William Shadrick, et al.
Plos One
|
May 30, 2020
An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications
Yihui Shi, Walter Bray, Alexander J Smith, et al.
Cancer Science
|
November 17, 2007
Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus
Geneviève Clément, Isabelle Guilleret, Biao He, et al.
Biorxiv : the Preprint Server for Biology
|
December 22, 2025
Oncometabolite fumarate impairs ATR-CHK1 signaling by succinating RPA1 in Fumarate Hydratase-deficient renal cell carcinoma cells
Nian Liu, Changxian Shen, Tingting Zhou, et al.
Biochemical and Biophysical Research Communications
|
March 7, 2006
Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma
Sonny Batra, Yihui Shi, Kristopher M Kuchenbecker, et al.
Journal of Translational Medicine
|
August 13, 2024
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK
Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, et al.
International Journal of Cancer
|
May 31, 2007
Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells
Yihui Shi, Biao He, Kristopher M Kuchenbecker, et al.
Human Gene Therapy
|
May 3, 2007
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth
Yu-Ching Lin, Liang You, Zhidong Xu, et al.
Angiogenesis
|
November 25, 2010
SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo
Wan-Ru Chao, Khalid Amin, Yihui Shi, et al.
The Journal of Clinical Investigation
|
July 10, 2025
Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockade
Imran Khan, Aida Rodriguez-Brotons, Anukana Bhattacharjee, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Pharmacology Research & Perspectives
|
July 15, 2015
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates
Yihui Shi, Amanda S Joyner, William Shadrick, et al.
Plos One
|
May 30, 2020
An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications
Yihui Shi, Walter Bray, Alexander J Smith, et al.
Cancer Science
|
November 17, 2007
Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus
Geneviève Clément, Isabelle Guilleret, Biao He, et al.
Biorxiv : the Preprint Server for Biology
|
December 22, 2025
Oncometabolite fumarate impairs ATR-CHK1 signaling by succinating RPA1 in Fumarate Hydratase-deficient renal cell carcinoma cells
Nian Liu, Changxian Shen, Tingting Zhou, et al.
Biochemical and Biophysical Research Communications
|
March 7, 2006
Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma
Sonny Batra, Yihui Shi, Kristopher M Kuchenbecker, et al.
Journal of Translational Medicine
|
August 13, 2024
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK
Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, et al.
International Journal of Cancer
|
May 31, 2007
Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells
Yihui Shi, Biao He, Kristopher M Kuchenbecker, et al.
Human Gene Therapy
|
May 3, 2007
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth
Yu-Ching Lin, Liang You, Zhidong Xu, et al.
Angiogenesis
|
November 25, 2010
SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo
Wan-Ru Chao, Khalid Amin, Yihui Shi, et al.
The Journal of Clinical Investigation
|
July 10, 2025
Combinatorial therapy regimens targeting preclinical models of melanoma resistant to immune checkpoint blockade
Imran Khan, Aida Rodriguez-Brotons, Anukana Bhattacharjee, et al.
Page
of 5